Neisseria meningitidis DNA vaccine (PowderJect)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNeisseria meningitidis DNA vaccine (PowderJect)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMeningococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPowderJect Vaccines Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPowderJect Vaccines Inc

Active IndicationsN/A

Inactive IndicationsMeningococcal Infections

Other Information

ATC CodeN/A